Masimo Corp

Masimo Corp

Masimo Corporation develops and manufactures medical technology products.

Stock Performance Snapshot

Buy

Analyst Rating

Analysts recommend buying Masimo's stock with a target price of $182.57, indicating strong growth potential.

Above Average

Financial Health

Masimo Corp is producing solid revenue and profits, with strong cash flow supporting its operations.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Baskets Featuring MASI

Wearable Health Stocks: Growth Potential vs Competition

Wearable Health Stocks: Growth Potential vs Competition

Apple's recent FDA clearance for its Apple Watch hypertension feature marks a major step in wearable medical technology. This development opens up investment opportunities in the broader ecosystem of connected health devices and remote patient monitoring services.

Published: September 12, 2025

Explore Basket
Wearable Tech IP Wars: What Investors Should Know

Wearable Tech IP Wars: What Investors Should Know

Masimo's lawsuit against U.S. Customs, following a reversal of an import ban on Apple Watches, highlights the fierce competition over intellectual property in wearable health. This theme focuses on the medical technology companies and competitors poised to benefit from the ongoing patent battles in the lucrative health-monitoring device market.

Published: August 21, 2025

Explore Basket

Why You’ll Want to Watch This Stock

πŸ“ˆ

Non‑invasive monitoring

Masimo’s core sensors and monitors address steady clinical demand for safer, continuous vital‑sign tracking β€” though sales can fluctuate with hospital procurement cycles.

🌍

Hospital to home

Growing interest in remote and home monitoring could expand Masimo’s addressable market, while reimbursement and regulatory pathways remain key variables.

⚑

Technology differentiator

R&D and intellectual property underpin Masimo’s product positioning, but patent disputes and competition are ongoing considerations for investors.

Why invest with Nemo?

Nemo Logo Fade
πŸ†“

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

πŸ”’

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

πŸ’°

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

ABT

Abbott Laboratories

Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.

TMO

Thermo Fisher Scientific, Inc.

Thermo Fisher provides a range of services and products that help customers advance their research, solve complex analytical challenges, improve patient diagnostics, and increase laboratory productivity.

ISRG

Intuitive Surgical, Inc.

A healthcare company that develops, manufactures, and markets robotic-assisted surgical systems for procedures in multiple specialties

Frequently asked questions